Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.

Aldosterone-specific activation of cardiomyocyte mineralocorticoid receptor in vivo.

Messaoudi S, Gravez B, Tarjus A, Pelloux V, Ouvrard-Pascaud A, Delcayre C, Samuel J, Launay JM, Sierra-Ramos C, Alvarez de la Rosa D, Clément K, Farman N, Jaisser F.

Hypertension. 2013 Feb;61(2):361-7. doi: 10.1161/HYPERTENSIONAHA.112.198986. Epub 2013 Jan 7.

2.

Atrial natriuretic peptide locally counteracts the deleterious effects of cardiomyocyte mineralocorticoid receptor activation.

Nakagawa H, Oberwinkler H, Nikolaev VO, Gaßner B, Umbenhauer S, Wagner H, Saito Y, Baba HA, Frantz S, Kuhn M.

Circ Heart Fail. 2014 Sep;7(5):814-21. doi: 10.1161/CIRCHEARTFAILURE.113.000885. Epub 2014 Jul 15.

3.

The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation.

Lavall D, Selzer C, Schuster P, Lenski M, Adam O, Schäfers HJ, Böhm M, Laufs U.

J Biol Chem. 2014 Mar 7;289(10):6656-68. doi: 10.1074/jbc.M113.519256. Epub 2014 Jan 27.

4.

The diuretic torasemide does not prevent aldosterone-mediated mineralocorticoid receptor activation in cardiomyocytes.

Gravez B, Tarjus A, Jimenez-Canino R, El Moghrabi S, Messaoudi S, Alvarez de la Rosa D, Jaisser F.

PLoS One. 2013 Sep 9;8(9):e73737. doi: 10.1371/journal.pone.0073737. eCollection 2013.

5.

Mineralocorticoid Receptor Blockade Improves Insulin Sensitivity in the Rat Heart and a Possible Molecular Mechanism.

Wang M, Li Y, Zhou K, Zhang G, Wang Y, Liu T, Zhang Y, Guo A, An Y.

Cell Physiol Biochem. 2016;39(3):860-70. doi: 10.1159/000447796. Epub 2016 Aug 9.

6.

Aldosterone upregulates connective tissue growth factor gene expression via p38 MAPK pathway and mineralocorticoid receptor in ventricular myocytes.

Lee YS, Kim JA, Kim KL, Jang HS, Kim JM, Lee JY, Shin IS, Lee JS, Suh W, Choi JH, Jeon ES, Byun J, Kim DK.

J Korean Med Sci. 2004 Dec;19(6):805-11.

7.

Rac1-Mediated Activation of Mineralocorticoid Receptor in Pressure Overload-Induced Cardiac Injury.

Ayuzawa N, Nagase M, Ueda K, Nishimoto M, Kawarazaki W, Marumo T, Aiba A, Sakurai T, Shindo T, Fujita T.

Hypertension. 2016 Jan;67(1):99-106. doi: 10.1161/HYPERTENSIONAHA.115.06054. Epub 2015 Nov 2.

8.

Mineralocorticoid receptor overexpression in embryonic stem cell-derived cardiomyocytes increases their beating frequency.

Le Menuet D, Munier M, Meduri G, Viengchareun S, Lombès M.

Cardiovasc Res. 2010 Aug 1;87(3):467-75. doi: 10.1093/cvr/cvq087. Epub 2010 Mar 17.

9.

Molecular signature of mineralocorticoid receptor signaling in cardiomyocytes: from cultured cells to mouse heart.

Latouche C, Sainte-Marie Y, Steenman M, Castro Chaves P, Naray-Fejes-Toth A, Fejes-Toth G, Farman N, Jaisser F.

Endocrinology. 2010 Sep;151(9):4467-76. doi: 10.1210/en.2010-0237. Epub 2010 Jun 30.

10.

Transgenic model of aldosterone-driven cardiac hypertrophy and heart failure.

Qin W, Rudolph AE, Bond BR, Rocha R, Blomme EA, Goellner JJ, Funder JW, McMahon EG.

Circ Res. 2003 Jul 11;93(1):69-76. Epub 2003 Jun 5.

11.

Rac1 GTPase regulates 11β hydroxysteroid dehydrogenase type 2 and fibrotic remodeling.

Lavall D, Schuster P, Jacobs N, Kazakov A, Böhm M, Laufs U.

J Biol Chem. 2017 May 5;292(18):7542-7553. doi: 10.1074/jbc.M116.764449. Epub 2017 Mar 20.

PMID:
28320863
12.

Contribution of mineralocorticoid and glucocorticoid receptors to the chronotropic and hypertrophic actions of aldosterone in neonatal rat ventricular myocytes.

Rossier MF, Python M, Maturana AD.

Endocrinology. 2010 Jun;151(6):2777-87. doi: 10.1210/en.2009-1375. Epub 2010 Apr 14.

PMID:
20392829
13.

Elevated cardiac tissue level of aldosterone and mineralocorticoid receptor in diastolic heart failure: Beneficial effects of mineralocorticoid receptor blocker.

Ohtani T, Ohta M, Yamamoto K, Mano T, Sakata Y, Nishio M, Takeda Y, Yoshida J, Miwa T, Okamoto M, Masuyama T, Nonaka Y, Hori M.

Am J Physiol Regul Integr Comp Physiol. 2007 Feb;292(2):R946-54. Epub 2006 Oct 5.

14.

Non-genomic effects of spironolactone and eplerenone in cardiomyocytes of neonatal Wistar rats: do they evoke cardioprotective pathways?

Hermidorff MM, Faria Gde O, Amâncio Gde C, de Assis LV, Isoldi MC.

Biochem Cell Biol. 2015 Feb;93(1):83-93. doi: 10.1139/bcb-2014-0110. Epub 2014 Oct 13.

PMID:
25488178
15.

Molecular mechanisms of mineralocorticoid receptor antagonism by eplerenone.

Hu X, Li S, McMahon EG, Lala DS, Rudolph AE.

Mini Rev Med Chem. 2005 Aug;5(8):709-18. Review.

PMID:
16101407
16.

Eplerenone mimics features of the alternative activation in macrophages obtained from patients with heart failure and healthy volunteers.

Łabuzek K, Liber S, Bułdak Ł, Krupej-Kędzierska J, Machnik G, Bobrzyk M, Okopień B.

Eur J Pharmacol. 2014 Mar 5;726:96-108.

PMID:
24486397
17.

Endothelial mineralocorticoid receptor activation mediates endothelial dysfunction in diet-induced obesity.

Schäfer N, Lohmann C, Winnik S, van Tits LJ, Miranda MX, Vergopoulos A, Ruschitzka F, Nussberger J, Berger S, Lüscher TF, Verrey F, Matter CM.

Eur Heart J. 2013 Dec;34(45):3515-24. doi: 10.1093/eurheartj/eht095. Epub 2013 Apr 17.

18.

Reversible cardiac fibrosis and heart failure induced by conditional expression of an antisense mRNA of the mineralocorticoid receptor in cardiomyocytes.

Beggah AT, Escoubet B, Puttini S, Cailmail S, Delage V, Ouvrard-Pascaud A, Bocchi B, Peuchmaur M, Delcayre C, Farman N, Jaisser F.

Proc Natl Acad Sci U S A. 2002 May 14;99(10):7160-5. Epub 2002 May 7.

19.

Early aldosterone-regulated genes in cardiomyocytes: clues to cardiac remodeling?

Fejes-Tóth G, Náray-Fejes-Tóth A.

Endocrinology. 2007 Apr;148(4):1502-10. Epub 2007 Jan 18.

PMID:
17234708
20.

Aldosterone, but not angiotensin II, reduces angiotensin converting enzyme 2 gene expression levels in cultured neonatal rat cardiomyocytes.

Yamamuro M, Yoshimura M, Nakayama M, Abe K, Sumida H, Sugiyama S, Saito Y, Nakao K, Yasue H, Ogawa H.

Circ J. 2008 Aug;72(8):1346-50.

Supplemental Content

Support Center